Development of malignancy following lung transplantation

Anat Amital1, David Shitrit, Yael Raviv

  • 1Pulmonary Institute, Rabin Medical Center, Belinson Campus, and Tel Aviv University, Tel Aviv, Israel.

Transplantation
|February 24, 2006
PubMed
Summary

Malignancy is common after lung transplantation, with higher rates of skin and bladder cancers observed. Reducing immunosuppression and sun avoidance may lower cancer risk in transplant patients.

Related Concept Videos